<DOC>
	<DOCNO>NCT02806479</DOCNO>
	<brief_summary>This study evaluate mechanism arrhythmogenicity hypertrophic cardiomyopathy , comparison patient well-understood arrhythmogenic substrate ( ischemic cardiomyopathy ) , well individual free arrhythmogenic substrate</brief_summary>
	<brief_title>Hypertrophic Cardiomyopathy Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Cardiomyopathies</mesh_term>
	<mesh_term>Hypertrophy</mesh_term>
	<mesh_term>Cardiomyopathy , Hypertrophic</mesh_term>
	<criteria>Diagnosed HCM Documented history sustain ventricular tachyarrhythmia resuscitate sudden cardiac arrest Maximal leave ventricular wall thickness &gt; 30mm Extensive fibrosis cardiac MRI ( &gt; 15 % total myocardial volume ) &gt; 7.5 % /5year risk sudden cardiac death determine HCM riskSCD age &lt; 18 year Pregnancy Atrial Fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>